SPAGNOLO, Calogera Claudia
SPAGNOLO, Calogera Claudia
Dipartimento di Scienze biomediche, odontoiatriche e delle immagini morfologiche e funzionali
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do
2022-01-01 Zito, C; Manganaro, R; Ciappina, G; Spagnolo, Cc; Racanelli, V; Santarpia, M; Silvestris, N; Carerj, S
Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors: a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient
2024-01-01 Spagnolo, Calogera Claudia; Campo, Irene; Campennì, Alfredo; Cardile, Davide; Cannavò, Salvatore; Silvestris, Nicola; Santarpia, Mariacarmela; Ruggeri, Rosaria Maddalena
Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?
2024-01-01 Spagnolo, Calogera Claudia; Pepe, Francesco; Ciappina, Giuliana; Nucera, Francesco; Ruggeri, Paolo; Squeri, Andrea; Speranza, Desirèe; Silvestris, Nicola; Malapelle, Umberto; Santarpia, Mariacarmela
Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
2023-01-01 Lazzari, Chiara; Spagnolo, Calogera Claudia; Ciappina, Giuliana; Di Pietro, Martina; Squeri, Andrea; Passalacqua, Maria Ilenia; Marchesi, Silvia; Gregorc, Vanesa; Santarpia, Mariacarmela
Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario
2023-01-01 Spagnolo, Calogera Claudia; Giuffrida, Giuseppe; Cannavo', Salvatore; Franchina, Tindara; Silvestris, Nicola; Ruggeri, Rosaria Maddalena; Santarpia, Mariacarmela
Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need
2023-01-01 Pretelli, Giulia; Spagnolo, Calogera Claudia; Ciappina, Giuliana; Santarpia, Mariacarmela; Pasello, Giulia
Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center
2023-01-01 Ruggeri, R M; Spagnolo, C C; Alibrandi, A; Silvestris, N; Cannavò, S; Santarpia, M
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review
2023-01-01 Santarpia, Mariacarmela; Ciappina, Giuliana; Spagnolo, Calogera Claudia; Squeri, Andrea; Passalacqua, Maria Ilenia; Aguilar, Andrés; Gonzalez-Cao, Maria; Giovannetti, Elisa; Silvestris, Nicola; Rosell, Rafael
Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
2023-01-01 Spagnolo, Calogera Claudia; Ciappina, Giuliana; Giovannetti, Elisa; Squeri, Andrea; Granata, Barbara; Lazzari, Chiara; Pretelli, Giulia; Pasello, Giulia; Santarpia, Mariacarmela
Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives
2023-01-01 Passalacqua, Maria Ilenia; Ciappina, Giuliana; Di Pietro, Martina; Spagnolo, Calogera Claudia; Squeri, Andrea; Granata, Barbara; Muscolino, Paola; Santarpia, Mariacarmela
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do | 1-gen-2022 | Zito, C; Manganaro, R; Ciappina, G; Spagnolo, Cc; Racanelli, V; Santarpia, M; Silvestris, N; Carerj, S | |
| Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors: a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient | 1-gen-2024 | Spagnolo, Calogera Claudia; Campo, Irene; Campennì, Alfredo; Cardile, Davide; Cannavò, Salvatore; Silvestris, Nicola; Santarpia, Mariacarmela; Ruggeri, Rosaria Maddalena | |
| Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path? | 1-gen-2024 | Spagnolo, Calogera Claudia; Pepe, Francesco; Ciappina, Giuliana; Nucera, Francesco; Ruggeri, Paolo; Squeri, Andrea; Speranza, Desirèe; Silvestris, Nicola; Malapelle, Umberto; Santarpia, Mariacarmela | |
| Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives | 1-gen-2023 | Lazzari, Chiara; Spagnolo, Calogera Claudia; Ciappina, Giuliana; Di Pietro, Martina; Squeri, Andrea; Passalacqua, Maria Ilenia; Marchesi, Silvia; Gregorc, Vanesa; Santarpia, Mariacarmela | |
| Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario | 1-gen-2023 | Spagnolo, Calogera Claudia; Giuffrida, Giuseppe; Cannavo', Salvatore; Franchina, Tindara; Silvestris, Nicola; Ruggeri, Rosaria Maddalena; Santarpia, Mariacarmela | |
| Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need | 1-gen-2023 | Pretelli, Giulia; Spagnolo, Calogera Claudia; Ciappina, Giuliana; Santarpia, Mariacarmela; Pasello, Giulia | |
| Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center | 1-gen-2023 | Ruggeri, R M; Spagnolo, C C; Alibrandi, A; Silvestris, N; Cannavò, S; Santarpia, M | |
| Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review | 1-gen-2023 | Santarpia, Mariacarmela; Ciappina, Giuliana; Spagnolo, Calogera Claudia; Squeri, Andrea; Passalacqua, Maria Ilenia; Aguilar, Andrés; Gonzalez-Cao, Maria; Giovannetti, Elisa; Silvestris, Nicola; Rosell, Rafael | |
| Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story? | 1-gen-2023 | Spagnolo, Calogera Claudia; Ciappina, Giuliana; Giovannetti, Elisa; Squeri, Andrea; Granata, Barbara; Lazzari, Chiara; Pretelli, Giulia; Pasello, Giulia; Santarpia, Mariacarmela | |
| Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives | 1-gen-2023 | Passalacqua, Maria Ilenia; Ciappina, Giuliana; Di Pietro, Martina; Spagnolo, Calogera Claudia; Squeri, Andrea; Granata, Barbara; Muscolino, Paola; Santarpia, Mariacarmela |